Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ABT

Abbott Laboratories (ABT)

Abbott Laboratories
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ABT
DateTimeSourceHeadlineSymbolCompany
04/26/20257:15PMPR Newswire (US)New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFibNYSE:ABTAbbott Laboratories
04/26/20257:15PMPR Newswire (US)New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFibNYSE:ABTAbbott Laboratories
04/16/20257:36AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:ABTAbbott Laboratories
04/16/20257:30AMPR Newswire (US)Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year GuidanceNYSE:ABTAbbott Laboratories
04/02/20255:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/02/20255:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/02/20255:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/02/20255:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
04/02/20255:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/31/20259:00AMPR Newswire (US)New Late-Breaking Data Reinforce Benefits of Abbott's TriClip™ for People With Leaky Tricuspid Heart ValveNYSE:ABTAbbott Laboratories
03/27/20259:00AMPR Newswire (US)Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart RhythmsNYSE:ABTAbbott Laboratories
03/27/20259:00AMPR Newswire (US)Abbott Receives CE Mark for its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart RhythmsNYSE:ABTAbbott Laboratories
03/26/20259:00AMPR Newswire (US)Abbott Hosts Conference Call for First-Quarter EarningsNYSE:ABTAbbott Laboratories
03/24/20259:00AMPR Newswire (US)Abbott Initiates New Intravascular Lithotripsy Clinical Trial to Improve Outcomes in Patients with Coronary Artery DiseaseNYSE:ABTAbbott Laboratories
03/14/20254:09PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNYSE:ABTAbbott Laboratories
03/14/20254:07PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:ABTAbbott Laboratories
03/14/20254:07PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNYSE:ABTAbbott Laboratories
03/07/20256:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
03/06/20255:47PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
03/04/20258:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20258:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20257:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20257:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20257:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20257:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20257:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20257:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20257:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/04/20257:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
03/03/20258:40PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
 Showing the most relevant articles for your search:NYSE:ABT